◇◆
<notes> Notes
Section-like container element for one or more notes that are not part of the narrative
flow (for example, note added in proof, dedication).
Usage/Remarks
Such notes are typically material outside the regular technical content of the document, extra material added by a contributor or by the publisher during
or after the regular text has been processed, a note by the editor, or a note added
after print publication.
There is no predefined list of types for the @notes-type attribute, but values publishers have used include
“added-in-proof”,
“dedication”,
“conflict-of-interest”,
“death-notice”,
“editor-note”,
“added-post-print”,
“added-post-electronic-publication”, and
“translator-note”.
A typical end-of-document note is a “Note in Proof”. A Note in Proof contains late-breaking
news items or other material produced while the document was being typeset or was
otherwise in production, that therefore happened too late to be included in the text
of the work. This is typically NOT peer-reviewed content, and citations to other material
within such content are usually integrated into the text or put inside the last paragraph,
not listed separately in a bibliographic reference list <ref-list>.
The possibility of prepublication online as well as slightly differing content in
the online versus print version of the same work has led to an increase in notes that
are “only for the print” or “only for web” versions. The @specific-use attribute may be used to mark a note as belonging to only a specific format, such
as
“print-only”.
Models and Context
May be contained in
Description
The following, in order:
- <sec-meta> Section Metadata, zero or one
- <label> Label (of an Equation, Figure, Reference, etc.), zero or one
- <title> Title, zero or one
- Any combination of:
- Paragraph-level Display Elements
- <address> Address/Contact Information
- <answer> Answer to a Question
- <answer-set> Answer Set
- <array> Array (Simple Tabulation)
- <block-alternatives> Block-level Alternatives
- <boxed-text> Boxed Text
- <chem-struct-wrap> Chemical Structure Wrapper
- <code> Code
- <explanation> Explanation
- <fig> Figure
- <fig-group> Figure Group
- <graphic> Graphic
- <media> Media Object
- <preformat> Preformatted Text
- <question> Question
- <question-wrap> Question Wrapper
- <question-wrap-group> Question Wrapper Group
- <supplementary-material> Supplementary Material Metadata
- <table-wrap> Table Wrapper
- <table-wrap-group> Table Wrapper Group
- <alternatives> Alternatives For Processing
- <disp-formula> Formula, Display
- <disp-formula-group> Formula, Display Group
- Lists
- Math Elements
- <p> Paragraph
- <related-article> Related Article Information
- <related-object> Related Object Information
- <ack> Acknowledgments
- <disp-quote> Quote, Displayed
- <speech> Speech
- <statement> Statement, Formal
- <verse-group> Verse Form for Poetry
- <x> X - Generated Text and Punctuation
- Paragraph-level Display Elements
- <sec> Section, zero or more
- Any combination of:
Content Model
<!ELEMENT notes %notes-model; >
Expanded Content Model
(sec-meta?, label?, title?, (address | alternatives | answer | answer-set | array | block-alternatives | boxed-text | chem-struct-wrap | code | explanation | fig | fig-group | graphic | media | preformat | question | question-wrap | question-wrap-group | supplementary-material | table-wrap | table-wrap-group | disp-formula | disp-formula-group | def-list | list | tex-math | mml:math | p | related-article | related-object | ack | disp-quote | speech | statement | verse-group | x)*, (sec)*, (notes | fn-group | glossary | ref-list)*)
Tagged Samples
Note added in proof
...
<back>
<glossary>...</glossary>
<notes>
<sec>
<title>Note Added in Proof</title>
<p>Similar sequence information has been obtained in another
study (S. Mishiro, personal communication) and has been
deposited under GenBank accession numbers –. For
the purposes of HBV nomenclature, we have proposed that
the chimpanzee HBV be abbreviated as ChHBV.</p>
</sec>
</notes>
<ref-list>...</ref-list>
...
</back>
...
Boilerplate
...
<front>
...
<article-meta>...</article-meta>
<notes notes-type="disclaimer">
<p><italic>The information and/or opinions expressed in this
Guest Editorial are those of the author(s). They are neither
endorsed nor disputed by <roman>Prescribing Physician</roman>
or the Pharma-Physician Coalition. Questions about or comments
on this editorial’s content should be directed to the
corresponding author.</italic></p>
</notes>
</front>
...
Dedication
...
<front>
...
<article-meta>...</article-meta>
<notes notes-type="dedication">
<p>We dedicate this paper to our professor, Dr. Robert
Jemmings, whose critique of the underlying study identified
potential bias in the analysis and strengthened our
argument.</p>
</notes>
</front>
...
Editor’s notes
...
<front>
...
<article-meta>...</article-meta>
<notes notes-type="editor-note">
<p><sc>EDITOR’S NOTE:</sc> The study examined in
this article was neither blinded nor placebo-controlled.
More recent studies suggest that traditional medications
when compared with placebos do decrease symptoms of this
condition. Further research is needed to ascertain the
efficacy of such medications; until research is conducted,
traditional medications may be an effectual treatment.</p>
</notes>
</front>
...
Post publication information
...
<front>
...
<article-meta>...</article-meta>
<notes notes-type="after-epub">
<p>After publication, the authors discovered an error in
the text concerning the administration of the medication
levothyroxine. The text reads: “Individuals
prescribed the thyroid hormone, levothyroxine, should
eat within thirty minutes of taking the medication.”
The text should read: “Individuals prescribed the
thyroid hormone, levothyroxine, should <italic>not</italic>
eat within thirty minutes of taking the medication.”</p>
</notes>
</front>
...
Conflict of interest information
...
<front>
...
<article-meta>...</article-meta>
<notes notes-type="conflict-interest">
<p><bold>Competing interests:</bold> RM reports that
he is employed by an academic medical center that has
both intellectual property and performs clinical trials.
DK declares that he has no competing interests.</p>
</notes>
</front>
...